Showing results (31-40 of 352) with videos related to
Sort By:
Pageof 36
Annual Review of Pharmacology and Toxicology|September 14, 2011
Therapeutic targeting of the interleukin-6 receptorToshio Tanaka, Masashi Narazaki, Tadamitsu KishimotoBiologics : Targets & Therapy|April 18, 2014
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitorsToshio Tanaka, Yoshihiro Hishitani, Atsushi OgataFrontiers in Microbiology|March 30, 2012
Enhancing effects on vacuole-targeting fungicidal activity of amphotericin BAkira Ogita, Ken-Ichi Fujita, Toshio TanakaPlanta Medica|December 5, 2008
Enhancement of the fungicidal activity of amphotericin B by allicin: effects on intracellular ergosterol traffickingAkira Ogita, Ken-Ichi Fujita, Toshio TanakaAnimal Science Journal = Nihon Chikusan Gakkaiho|January 29, 2011
Behavioral indexes of piglet welfare: comparison of indoor and outdoor housing systemsKouzo Nakamura, Toshio Tanaka, Kouji Nishida, et al.The Journal of Infection|October 19, 2005
An unusual case of thrombocytosis associated with concurrent cytomegalovirus and respiratory syncytial virus infection in an immunocompetent infant: possible roles of thrombopoietin and interleukin-6Izumi Akaboshi, Kaoru Fugita, Akio Abe, et al.Journal of Bioscience and Bioengineering|October 20, 2005
Improved production of isoamyl acetate by a sake yeast mutant resistant to an isoprenoid analog and its dependence on alcohol acetyltransferase activity, but not on isoamyl alcohol productionKiyoo Hirooka, Yoshihiro Yamamoto, Nobuo Tsutsui, et al.Case Reports in Rheumatology|February 21, 2013
Anti-interleukin-6 receptor antibody therapy-induced retinopathy in a patient with rheumatoid arthritisAsumi Tada, Noriyasu Hashida, Toshio Tanaka, et al.Scientific Reports|November 28, 2022
A prospective, randomized, open-label trial of early versus late povidone-iodine gargling in patients with COVID-19Akifumi Matsuyama, Hanayuki Okura, Shyoji Hashimoto, et al.Seminars in Immunology|March 6, 2014
A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategyToshio Tanaka, Masashi Narazaki, Atsushi Ogata, et al.Pageof 36